Literature DB >> 18622695

Three-dimensional pathological size assessment in primary breast carcinoma.

Uwe Güth1, Denise Brenckle, Dorothy Jane Huang, Andreas Schötzau, Carsten Thomas Viehl, Holger Dieterich, Wolfgang Holzgreve, Edward Wight, Gad Singer.   

Abstract

Maximal tumor diameter (MD) is traditionally an important prognostic factor in breast cancer. It must be questioned, however, how well a one-dimensional parameter alone can represent the actual morphologic condition of a three-dimensional body. Along with the pathologically assessed MD and two perpendicular diameters (PDs) of a lesion, eccentricity (EF) and the three-dimensional parameters tumor volume (TV) and surface area (TSA) of 395 ductal invasive breast carcinomas of limited size (10-40 mm) were calculated. The dependent prognostic variable was axillary lymph node involvement (ALNI). MD, TV and TSA area were highly significant predictors of ALNI; these variables had similar levels of prediction accuracy (univariate analyses: MD: P = 0.0003, TV: P = 0.0009, TSA: P < 0.0001; multivariate analyses: MD: P = 0.0018, TV: P = 0.0109, TSA: P = 0.0009; pseudo R-squared values: MD: 0.42, TV: 0.39, TSA: 0.39). Despite certain variations in tumor shape, TV and TSA with similar MD, there is no evidence that three-dimensional pathologic measurements (TV/TSA) are more precise prognostic predictors of ALNI compared to the one-dimensional measurement alone.

Entities:  

Mesh:

Year:  2008        PMID: 18622695     DOI: 10.1007/s10549-008-0115-1

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  2 in total

1.  3D Pathology Volumetric Technique: A Method for Calculating Breast Tumour Volume from Whole-Mount Serial Section Images.

Authors:  G M Clarke; M Murray; C M B Holloway; K Liu; J T Zubovits; M J Yaffe
Journal:  Int J Breast Cancer       Date:  2012-12-23

2.  Elastic free energy drives the shape of prevascular solid tumors.

Authors:  K L Mills; Ralf Kemkemer; Shiva Rudraraju; Krishna Garikipati
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.